SF_Wolf:
I just found it yesterday, but it is a great overview of the state of affairs.
Top scientists in industry and government are STILL going after Beta-Amyloid and Tau as primary targets. And "The Street", funds, institutions and retail investors are following like sheep.
SGMO just released a news release yesterday that they have new animal model data (human in vitro), using their zinc finger gene technology, that eliminates 90% of tau...and the stock is up almost 20% from 2 days ago.
Even after all the years of trial failures in treating Beta-Amyloid and Tau, publish a news release that states reduces or eliminates these symptoms, and it's greeted with an increased share price.
"The Street", fund managers, investors, scientists, biotech companies are mesmerized. About to change dramatically in a few weeks, I hope.
News 
Market Data 
Discover 
